Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Cover, C; Fickert, P; Knight, TR; Fuchsbichler, A; Farhood, A; Trauner, M; Jaeschke, H.
Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
Toxicol Sci. 2005; 84(1):201-208
Doi: 10.1093/toxsci/kfi065
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fickert Peter
- Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- DNA fragmentation in hepatocytes occurs early after acetaminophen (AAP) overdose in mice. DNA strandbreaks can induce excessive activation of poly(ADP-ribose) polymerases (PARP), which may lead to oncotic necrosis. Based on controversial findings with chemical PARP inhibitors, the role of PARP-1 activation in AAP hepatotoxicity remains unclear. To investigate PARP-1 activation and evaluate a pathophysiological role of PARP-1, we used both PARP inhibitors (3-aminobenzamide; 5-aminoisoquinolinone) and PARP gene knockout mice (PARP-/-). Treatment of C3Heb/FeJ mice with 300 mg/kg AAP resulted in DNA fragmentation and alanine aminotransferase (ALT) release as early as 3 h, with further increase of these parameters up to 12 h. Few nuclei of hepatocytes stained positive for poly-ADP-ribosylated nuclear proteins (PAR) as indicator for PARP-1 activation at 4.5 h. However, the number of PAR-positive cells and staining intensity increased substantially at 6 and 12 h. Pretreatment with 500 mg/kg 3-aminobenzamide before AAP attenuated hepatic glutathione depletion and completely eliminated DNA fragmentation and liver injury. Delayed treatment several hours after AAP was still partially protective. On the other hand, liver injury was not attenuated in PARP-/- mice compared to wild-type animals. Similarly, the specific PARP-1 inhibitor 5-aminoisoquinolinone (5 mg/kg) was not protective. However, 3-aminobenzamide attenuated liver injury in WT and PARP-/- mice. In summary, PARP-1 activation is a consequence of DNA fragmentation after AAP overdose. However, PARP-1 activation is not a relevant event for AAP-induced oncotic necrosis. The protection of 3-aminobenzamide against AAP-induced liver injury was due to reduced metabolic activation and potentially its antioxidant effect but independent of PARP-1 inhibition.
- Find related publications in this database (using NLM MeSH Indexing)
- Acetaminophen - toxicity
- Analgesics, Non-Narcotic - toxicity
- Animals -
- Benzamides - pharmacology
- Biotransformation - physiology
- DNA Fragmentation - drug effects
- Drug-Induced Liver Injury - pathology Drug-Induced Liver Injury - physiopathology
- Enzyme Inhibitors - pharmacology
- Immunohistochemistry -
- Isoquinolines - pharmacology
- Liver - pathology Liver - physiopathology
- Male -
- Mice -
- Mice, Inbred C3H -
- Mice, Knockout -
- Necrosis -
- Poly(ADP-ribose) Polymerases - antagonists & inhibitors Poly(ADP-ribose) Polymerases - genetics Poly(ADP-ribose) Polymerases - physiology
- Find related publications in this database (Keywords)
- acetaminophen
- hepatotoxicity
- poly(ADP-ribose) polymerase-1 (PARP-1)
- DNA fragmentation
- 3-aminobenzamide